Glyset (miglitol), a new alpha-glucosidase inhibitor for type 2 diabetes
February 1999
Pharmacia & Upjohn is marketing Glyset (miglitol), a new alpha-glucosidase inhibitor for type 2 diabetes.
Glyset is a "me-too"...very similar to Precose (acarbose).
These drugs reduce postprandial hyperglycemia by slowing carbohydrate absorption in the small intestine. They also cause similar GI effects...flatulence, diarrhea, and abdominal discomfort.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote